The Sentinel


Monday, June 1, 2020

President's Message - June 2020

Dear Colleagues,

While the global coronavirus pandemic has held our attention since March, this edition of the President’s Message will focus on the greater mission that brings us all together.

June is Cancer Immunotherapy Awareness Month™, and so, first and most important, I would like to thank our members for the countless ways you contribute to advancing and delivery of cancer immunotherapy. Originally founded in 1984 as the Society for Biological Therapy by 40 charter members, SITC has proudly grown to more than 3,000 members representing 48 countries around the globe. Such growth could not have been possible if it were not for the sound, strategic leadership of my predecessors, who maintained their strong belief in this field despite substantial skepticism in other parts of the scientific community and the limited success of earlier therapies. Therefore, with the opportunity presented by Cancer Immunotherapy Month™, I would like to acknowledge all of SITC’s Past Presidents for their guidance, expertise and their continued contributions to our society.

This month, SITC will call attention to the many ways our society, through the contributions and dedication of its members, are positively affecting the field of cancer immunotherapy. On our website and social media channels, including Twitter, LinkedIn and Facebook, SITC will feature a different program, resource or SITC initiative each day of the month. Further, we will celebrate and honor the scientists, clinicians and many others in the field by wearing white on Friday, June 12. You can download SITC’s 2020 “Why I Wear White” flyer, take a selfie with a decorated flyer, and post it to social media. And don’t forget to tag SITC!

SITC staff and meeting organizers continue preparing for our society’s upcoming 35th Anniversary Annual Meeting (Nov. 10–15 in National Harbor, Md.). We look forward to seeing all of you there and I encourage you to register for what will be another outstanding meeting. We are monitoring world events closely and continue to place the safety of our members as our top priority. Please also note that enduring materials from the 34th Annual Meeting & Pre-Conference Programs (SITC 2019) are now available by open access to the general public. To access these and numerous other quality resources published from past SITC meetings, please visit the SITC Resource Library.

Finally, I want to bring to your attention again the remarkable progress and success of the Journal for ImmunoTherapy of Cancer (JITC), our society’s official open access journal. JITC received its first impact factor just two years ago, ranking it as one of the top cancer immunotherapy journals, and is currently receiving a record number of submissions. JITC will now also offer continuing medical education (CME) credits for its reviewers. Continue reading this month’s edition of the Immune Monitor to learn more about this valuable new feature from JITC.

I wish you all a happy and safe beginning to summer.


Mario Sznol, MD
SITC President

No comments:

Post a Comment